An article Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity WOS:000561619300002 published article about BIOSYNTHESIS; ENZYMES; IDENTIFICATION; DEHYDROGENASE; VALIDATION; METABOLISM; GENES in [Kim, Dong-Gyun; Cho, Sujin; Lee, Kyu-Yeon; Cheon, Seung-Ho; Kim, Dongyoon; Shin, Kwang-Soo; Koh, Choong-Hyun; Koo, Ji Sung; Oh, Yu-Kyoung; Jeong, Yoo-Seong; Chung, Suk-Jae; Lee, Bong-Jin] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 08826, South Korea; [Yoon, Hye-Jin; Choi, Yuri; Lee, Hyung Ho] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 08826, South Korea; [Lee, Joo-Youn] Korea Res Inst Chem Technol, Chem Data Driven Res Ctr, Daejeon 34114, South Korea; [Baek, Moonkyu; Jung, Kwan-Young] Korea Res Inst Chem Technol, Therapeut & Biotechnol Div, Daejeon 34114, South Korea; [Jung, Kwan-Young] Univ Sci & Technol, Dept Med Chem & Pharmacol, Daejeon 34113, South Korea; [Lim, Hyo Jin; Kim, Hyoun Sook] Natl Canc Ctr, Res Inst, Goyang Si 10408, Gyeonggi Do, South Korea; [Park, Sung Jean] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Incheon 13120, South Korea; [Lee, Jeong-Yeon] Hanyang Univ, Coll Med, Dept Med, Seoul 04763, South Korea; [Lee, Sang Jae] POSTECH, Pal XFEL, Pohang Accelerator Lab, Pohang 37673, Gyeongbuk, South Korea in 2021.0, Cited 50.0. The Name is 1-Chloro-2-methylbenzene. Through research, I have a further understanding and discovery of 95-49-8. Recommanded Product: 1-Chloro-2-methylbenzene
NAD(P)-dependent steroid dehydrogenase-like (NSDHL), an essential enzyme in human cholesterol synthesis and a regulator of epidermal growth factor receptor (EGFR) trafficking pathways, has attracted interest as a therapeutic target due to its crucial relevance to cholesterol-related diseases and carcinomas. However, the development of pharmacological agents for targeting NSDHL has been hindered by the absence of the atomic details of NSDHL. In this study, we reported two X-ray crystal structures of human NSDHL, which revealed a detailed description of the coenzyme-binding site and the unique conformational change upon the binding of a coenzyme. A structure-based virtual screening and biochemical evaluation were performed and identified a novel inhibitor for NSDHL harboring suppressive activity towards EGFR. In EGFR-driven human cancer cells, treatment with the potent NSDHL inhibitor enhanced the antitumor effect of an EGFR kinase inhibitor. Overall, these findings could serve as good platforms for the development of therapeutic agents against NSDHL-related diseases.
Recommanded Product: 1-Chloro-2-methylbenzene. Welcome to talk about 95-49-8, If you have any questions, you can contact Kim, DG; Cho, S; Lee, KY; Cheon, SH; Yoon, HJ; Lee, JY; Kim, D; Shin, KS; Koh, CH; Koo, JS; Choi, Y; Lee, HH; Oh, YK; Jeong, YS; Chung, SJ; Baek, M; Jung, KY; Lim, HJ; Kim, HS; Park, SJ; Lee, JY; Lee, SJ; Lee, BJ or send Email.
Reference:
Patent; Nanjing Zhongteng Chemical Co., Ltd.; Zhong Hua; Lu Minshan; Chen Xiuzhen; Liu Qiaobao; Yin Hengbo; Wang Aili; (8 pag.)CN104876790; (2017); B;,
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics